Concomitant administration of probenecid and acyclovir has reportedly increased the mean plasma half life and area under the plasma-concentration time curve (AUC) and decreased urinary excretion and renal clearance of acyclovir. This interaction may result from the competitive inhibition of renal secretion of acyclovir by probenecid.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
